5 Potential Breakout Catalysts Lift (Nasdaq: XXII) To Today's Top Watchlist Spot (Low Float)

Markets have been choppy lately, with uncertainty swirling as trends shift.

*Sponsored 5 Potential Breakout Catalysts Lift (Nasdaq: XXII) To Today's Top Watchlist Spot (Low Float) April 9th Dear Reader, Markets have been choppy lately, with uncertainty swirling as trends shift. But when conditions feel unpredictable, that’s often when the biggest opportunities can emerge. Right now, we’re unveiling a fresh idea with serious breakout potential. This isn’t about chasing the crowd—it’s about spotting what others might miss before any potential momentum builds. And here's what I'm recognizing: #1. A low float under 3Mn shares that could create the environment for heightened volatility potential. #2. An analyst target is suggesting over 1,000% potential upside from current chart levels. #3. Oversold technical indicators could suggest a healthy reversal nearing. With strong news surrounding this company early in 2025, this may be the perfect time to consider getting this breakout idea on your radar: *22nd Century Group, Inc. (Nasdaq: XXII)* 22nd Century Group, Inc. is a next-generation plant biotechnology company focused on to-bacco harm reduction, reduced nicotine to-bacco, and improving plants to enhance human health. Using their breakthrough, patent-protected IP to control nicotine biosynthesis in the to-bacco plant, they have developed the first market-ready, reduced nicotine content (RNC) to-bacco plants, and cig-a-rettes, containing 95% less nicotine. And based on several potential catalysts, XXII has topped my immediate watchlist. Take a look: No. 1 - A Float This Size Could Provide An Environment For Heightened Volatility. No. 2 - An Analyst $13 Target Suggest Over 1,000% Potential Upside From Current Levels. No. 3 - A New Agreement Could Act As A "Foundational Building Block" To Advance VLN In The Market. No. 4 - FDA Rule Cites Research Using XXII Products And Sales Activity. No. 5 - Key Oversold Technical Indicators May Suggest Strong Reversal Potential. But more on those in a second... Company Breakdown - 22nd Century Group, Inc. (Nasdaq: XXII) 22nd Century Group is a leading to-bacco products company focused on enabling smokers to manage their nicotine consumption. The company manufactures and distributes combustible to-bacco products containing reduced or non-addictive levels of nicotine. Its flagship product, the VLN® cig-a-rette, offers a solution for smokers who wish to reduce their nicotine intake. VLN® cig-a-rettes contain 95% less nicotine than conventional ci-g-arettes, providing an alternative that helps smokers control their consumption and potentially reduce dependence on nicotine. Founded on the principle of nicotine harm reduction, 22nd Century seeks to provide smokers with the freedom to choose how much nicotine they consume, rather than being forced into either quitting or continuing with addictive levels of nicotine. This innovative approach to to-bacco products has positioned the company as a unique player in the market, offering products that support smokers in their efforts to lower nicotine consumption. In December 2021, 22nd Century received Modified Risk To-bacco Product (MRTP) orders from the U.S. Food and Drug Administration (FDA) for its Reduced Nicotine Content (RNC) cig-a-rettes. These orders made 22nd Century the first company to receive FDA approval for a combusted to-bacco product with drastically reduced nicotine content. This milestone is a testament to the company's commitment to revolutionizing the to-bacco industry with its proprietary technologies, which regulate nicotine biosynthesis in the to-bacco plant, resulting in high-quality to-bacco with significantly reduced nicotine levels. The company operates a vertically integrated manufacturing process, which includes its own high-speed automated factory in Mocksville, North Carolina. This facility is capable of producing more than 45 million cartons of to-bacco products annually, supporting both 22nd Century's branded products and its contract manufacturing operations. Through its subsidiary NASCO Products, LLC, the company manufactures cig-a-rettes and ci-gars for other to-bacco brands, leveraging its expertise to attract additional business and lower unit costs. 22nd Century has expanded its market presence through pilot programs and retail studies, leading to significant product and branding enhancements. As of 2025, its VLN® cig-a-rettes are available in over 5,100 stores across 26 U.S. states. Beyond to-bacco, the company has also in-vest-ed in research and development (R&D) for bioengineering and nicotine biosynthesis, ensuring its leadership in the low-nicotine category. 22nd Century’s extensive patent portfolio and intellectual property protect its innovative approach to nicotine control, including the development of non-GMO low-nicotine to-bacco varieties. Through strategic R&D partnerships and ongoing product innovation, 22nd Century aims to expand its range of RNC products and improve to-bacco quality while meeting the evolving needs of to-bacco users worldwide. (Nasdaq: XXII) - 2025 Growth Strategies Grab Sources: XXII Presentation. XXII Website. ----- And as I mentioned above, (Nasdaq: XXII) has multiple potential catalysts to focus on right now. Check them out: No. 1 XXII Potential Catalyst - A Float This Size Could Provide An Environment For Heightened Volatility. According to the Yahoo Finance website, XXII has a low float. In fact, the website reports this profile to have approximately 2.21Mn shares in its float. Why is that important? It's important on one crucial level. Volatility potential. If the company provides more positive company news in the first half of 2025, could it provide a near term spark? ----- No. 2 XXII Potential Catalyst - An Analyst $13 Target Suggest Over 1,000% Potential Upside From Current Levels. Back in February, coverage was initiated on XXII by Emerging Growth Research. In their report, they tagged XXII with a massive $13 analyst target. From Tuesday's closing valuation, that target suggests over 1,000% in potential upside for XXII. Here's a highlight from the report: Near-term upside is extraordinary based on DCF analysis relative to hammered XXII shares. Therefore, the question is will new management be able to grow the business? We are inclined to believe, so we are bullish on XXII. We initiate with a Buy-Emerging rating with a $13.00 price target. ----- No. 3 XXII Potential Catalyst - A New Agreement Could Act As A "Foundational Building Block" To Advance VLN In The Market. 22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly Smoker Friendly Adds Both VLN and Smoker Friendly Branded VLN Reduced Nicotine Content Products to its Store Lineup MOCKSVILLE, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), ..., today announced that it has signed an agreement with Smoker Friendly, one of its largest customers, to launch Smoker Friendly VLN branded reduced nicotine content cig-a-rette products that will become the first VLN partner brand. The introduction of Smoker Friendly VLN and 22nd Century VLN in Smoker Friendly outlets will be one of the first presentations of gold and menthol SKU’s that introduce the new VLN branding. The addition of Smoker Friendly branded VLN and 22nd Century Group’s VLN products builds on a customer relationship of over 10 years, as does the recent addition of the Smoker Friendly Black Label style cig-a-rette. The Companies are currently obtaining state approvals for these products and expect to begin shipping in the second quarter of 2025. Larry Firestone, Chief Executive Officer of 22nd Century, said, “We are very excited to have Smoker Friendly adopt our first VLN partner brand and also add our newly rebranded VLN products to the Smoker Friendly product offerings in their stores. This is a foundational building block to advancing VLN in the market, and will be a staged rollout as we garner state approvals. Equally important to expanding distribution will be measuring rate of sale once VLN is on the shelf.” ... Read the full article here. ----- No. 4 XXII Potential Catalyst - FDA Rule Cites Research Using XXII Products And Sales Activity. FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cig-a-rette That Complies with the New Standard New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity Proposed Standard Designates VLNC as a New Product Category, 22nd Century Ready to Manufacture as Needed to Quickly Expand Commercialization and Distribution FDA Expects Proposed Product Standard Would Significantly Reduce the Morbidity and Mortality Caused by Smoking MOCKSVILLE, N.C., Jan. 15, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), ..., today heralded the publication of a proposed new To-bacco Product Standard for Nicotine Yield of Cig-a-rettes and Certain Other Combusted To-bacco Products by the U.S. Food and Drug Administration. The new proposed standard would set a maximum nicotine content of 0.7 mg nicotine per gram of to-bacco in cig-a-rettes and certain other combusted to-bacco products and take effect in two years from final approval. 22nd Century’s VLN products – the only combustible cig-a-rettes authorized by the FDA as a reduced nicotine content product – already comply with this standard and are available in more than 5,000 stores across the country. “After 26 years of commitment to nicotine harm reduction, the FDA is now clearing the path for commercial adoption of our very important VLN reduced nicotine content to-bacco products in what could be the most game-changing public health policy of a generation,” said Larry Firestone, Chief Executive Officer of 22nd Century Group. Read the full article here. ----- No. 5 XXII Potential Catalyst - Key Oversold Technical Indicators May Suggest Strong Reversal Potential. At 4:00PM EST Tuesday, Barchart was reporting multiple oversold leaning technical indicators for XXII. These technicals could be signaling a healthy reversal is approaching in the near term. Here's the definition of a "reversal" from Investopedia: "A reversal is a change in the price direction of an asset. A reversal can occur to the upside or downside. Following an uptrend, a reversal would be to the downside. Following a downtrend, a reversal would be to the upside. Reversals are based on overall price direction and are not typically based on one or two periods/bars on a chart." Here's the technicals to pay close attention to (as of 4:00PM EST Tuesday): 9-Day Relative Strength Index: 21.01% 14-Day Relative Strength Index: 24.87% When these numbers drop down to the 30% range and lower, they can be viewed as being in oversold territory. While in this territory, they can paint the picture of a profile that is undervalued. 14-Day Raw Stochastic: 4.11% 14-Day Williams %R: 95.89% As the Raw Stochastic nears the 10% range and lower and the Williams %R nears the 90% range or higher, these technical indicators may also be viewed as oversold and undervalued. Keep an eye on these technicals closely. ----- (Nasdaq: XXII) Recap - 5 Potential Catalysts To Consider Now No. 1 - A Float This Size Could Provide An Environment For Heightened Volatility. No. 2 - An Analyst $13 Target Suggest Over 1,000% Potential Upside From Current Levels. No. 3 - A New Agreement Could Act As A "Foundational Building Block" To Advance VLN In The Market. No. 4 - FDA Rule Cites Research Using XXII Products And Sales Activity. No. 5 - Key Oversold Technical Indicators May Suggest Strong Reversal Potential. ----- Coverage is officially initiated on 22nd Century Group, Inc. (Nasdaq: XXII). When updates are available, I'll have them out quickly. Talk soon. Sincerely, FierceAnalyst | Jaks Swift Editorial Writer (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.) *FierceInvestor (FierceInvestor . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and FierceInvestor ("FI") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors. Pursuant to an agreement between SWN Media LLC and TD Media LLC, SWN Media LLC has been hired for a period beginning on 04/08/2025 and ending on 04/09/2025 to publicly disseminate information about (XXII:US) via digital communications. Under this agreement, SWN Media LLC has been paid seventeen thousand five hundred USD (“Funds”). To date, including under the previously described agreement, SWN Media LLC has been paid fifty thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither SWN Media LLC, TD Media LLC and their member own shares of (XXII:US). Please see important disclosure information here: https://fierceinvestor.com/disclosure/xxii/#details

Fierce | 4834 NW 2nd Ave Unit #388 | Boca Raton, FL 33431 US Unsubscribe | Update Profile | Constant Contact Data Notice